Marker Therapeutics Inc (MRKR)

[hanscott]

For all of you who have stuck around all these years it about to crater big time if this on gong trial doesn’t show significant results to get an approval from the FDA. Even if it does I don’t see this stock ever getting back to my break even point of $5.25.

Why? If approved just for AML, and if there is not a better and less expensive treatment between now and then.

Do you think that between dilution and the low cost of treatment, that they won't be able to generate enough revenue to get the stock price that high?

-----------------------------

I think there is a good chance it will be approved. I just wonder how long it will take to reach full enrollment of this trial. I am not sure of the AML patient population size they can reach with the hospital network they have set up so far.

I think if it appears to work, the enrollment rate should increase bc more hospitals would want to be involved. But I don't know if that is how it works.

I think the therapy looked very promising for several kinds of blood cancers and for the pancreatic cancer trial. So I think it could be approved for those indications.

But I do not understand why they took down the data for all of the clinical trials from their web site? If someone is interested in this company and the main thing they would want to see is the trial data, I would think.

I would like to see the trail data myself, just for reassurance, lol.